Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2021 Feb 23;1188:. doi: 10.1073/pnas.2008178118.
Show Gene links
Show Anatomy links
Modulation of α1β3γ2 GABAA receptors expressed in X. laevis oocytes using a propofol photoswitch tethered to the transmembrane helix.
Borghese CM
,
Wang HL
,
McHardy SF
,
Messing RO
,
Trudell JR
,
Harris RA
,
Bertaccini EJ
.
???displayArticle.abstract???
Tethered photoswitches are molecules with two photo-dependent isomeric forms, each with different actions on their biological targets. They include reactive chemical groups capable of covalently binding to their target. Our aim was to develop a β-subunit-tethered propofol photoswitch (MAP20), as a tool to better study the mechanism of anesthesia through the GABAA α1β3γ2 receptor. We used short spacers between the tether (methanethiosulfonate), the photosensitive moiety (azobenzene), and the ligand (propofol), to allow a precise tethering adjacent to the putative propofol binding site at the β+α- interface of the receptor transmembrane helices (TMs). First, we used molecular modeling to identify possible tethering sites in β3TM3 and α1TM1, and then introduced cysteines in the candidate positions. Two mutant subunits [β3(M283C) and α1(V227C)] showed photomodulation of GABA responses after incubation with MAP20 and illumination with lights at specific wavelengths. The α1β3(M283C)γ2 receptor showed the greatest photomodulation, which decreased as GABA concentration increased. The location of the mutations that produced photomodulation confirmed that the propofol binding site is located in the β+α- interface close to the extracellular side of the transmembrane helices. Tethering the photoswitch to cysteines introduced in the positions homologous to β3M283 in two other subunits (α1W288 and γ2L298) also produced photomodulation, which was not entirely reversible, probably reflecting the different nature of each interface. The results are in agreement with a binding site in the β+α- interface for the anesthetic propofol.
Tethered photoswitch. (A) Methanethiosulfonate azobenzene propofol 2020 (MAP20) consists of propofol (ligand group), an azobenzene moiety (photosensitive), and a tether (methanethiosulfonate). (B) The azobenzene moiety can change between cis and trans isomeric forms depending on the wavelength of the light irradiated.
GABAA receptors containing β3(M283C) or α1(V227C) subunits. (A–D) Models of the β+α− interface (β in light gray, α in dark gray), with MAP20 attached to β3(M283C), depicted in blue (A and B) and α1(V227C), depicted in cyan (C and D). Propofol moiety from MAP20 in purple, residues lining the putative binding site of propofol at this interface in green. Side view of the interface as seen from the membrane in A and C. View of the interface from the extracellular side in B and D. The relative position of the models is indicated by the rotation axis and degree symbol. (E and H) Photopotentiation of submaximal GABA responses in α1β3(M283C)γ2 and α1(V227C)β3γ2 GABAA receptors. Representative tracings of photomodulation in (E) α1β3γ2 Cys-to-Ala, (F) α1β3(M283C)γ2, and (G) α1(V227C)β3γ2. Light wavelength: G (green), 520 nm; V (violet), 380 nm. (H) Quantitative summary of photomodulation in these receptors. Data are shown as mean ± SEM and were analyzed using one-way ANOVA, followed by Dunnett’s multiple comparisons test, *P P n = 4 to 5).
Photomodulation at different GABA concentrations after incubation with 50 µM MAP20. Representative tracings of (A) α1β3γ2 Cys-to-Ala and (B) α1β3(M283C)γ2 GABAA receptors. (C) Quantitative summary of the photomodulation at different GABA concentrations. Data are shown as mean ± SEM, error bars not shown are smaller than symbols. Data were analyzed using two-way repeated measures ANOVA, followed by Dunnett’s multiple comparisons test, ***P n = 4 to 5).
GABAA receptors containing α1(W288C) or γ2(L298C) subunits. (A and B) Model of the α+β− interface (α in dark gray, β in light gray), with MAP20 attached to α1(W288C) (in cyan). (C and D) Model of the γ+α− interface (γ in gold, α in dark gray), with MAP20 attached to γ2(L298C) (in cyan). Propofol moiety from MAP20 in purple, residues lining the putative binding site of propofol at this interface in green. Side view of the interface as seen from the membrane in A and C. View of the interface from the extracellular side in B and D. The relative position of the models is indicated by the rotation axis and degree symbol. (E–G) Photopotentiation of submaximal GABA responses in α1(W288C)β3γ2 and α1β3γ2(L298C) GABAA receptors. Representative tracings of photomodulation in (E) α1(W288C)β3γ2 and (F) α1β3γ2(L298C). Light wavelength: G (green), 520 nm; V (violet), 380 nm. (G) Quantitative summary of photomodulation in these mutants. Data are shown as mean ± SEM and analyzed using one-way ANOVA, followed by Dunnett’s multiple comparisons test, *P n = 4 to 8).
Diagram of the GABAA receptor transmembrane domains viewed from the extracellular side. MAP20 tethered to (A) β subunits, (B) α subunits, and (C) γ subunit. Orange circles mark the interfaces where putative binding sites for propofol exist (four binding sites, the α+γ− interface is apparently lacking a propofol binding site). MAP20 is shown as a black and purple sphere-shaped molecule, with purple representing the propofol moiety.
Bertaccini,
Assessment of homology templates and an anesthetic binding site within the γ-aminobutyric acid receptor.
2013, Pubmed
Bertaccini,
Assessment of homology templates and an anesthetic binding site within the γ-aminobutyric acid receptor.
2013,
Pubmed
Cayla,
A newly developed anesthetic based on a unique chemical core.
2019,
Pubmed
,
Xenbase
Chiara,
Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.
2013,
Pubmed
Forman,
Mapping General Anesthetic Sites in Heteromeric γ-Aminobutyric Acid Type A Receptors Reveals a Potential For Targeting Receptor Subtypes.
2016,
Pubmed
Forman,
Anesthetic sites and allosteric mechanisms of action on Cys-loop ligand-gated ion channels.
2011,
Pubmed
Hibbs,
Principles of activation and permeation in an anion-selective Cys-loop receptor.
2011,
Pubmed
Hüll,
In Vivo Photopharmacology.
2018,
Pubmed
Jayakar,
Multiple propofol-binding sites in a γ-aminobutyric acid type A receptor (GABAAR) identified using a photoreactive propofol analog.
2014,
Pubmed
Jayakar,
Identifying Drugs that Bind Selectively to Intersubunit General Anesthetic Sites in the α1β3γ2 GABAAR Transmembrane Domain.
2019,
Pubmed
Jurd,
General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit.
2003,
Pubmed
Kim,
Shared structural mechanisms of general anaesthetics and benzodiazepines.
2020,
Pubmed
Krasowski,
Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane.
1998,
Pubmed
Li,
Numerous classes of general anesthetics inhibit etomidate binding to gamma-aminobutyric acid type A (GABAA) receptors.
2010,
Pubmed
Lin,
A Comprehensive Optogenetic Pharmacology Toolkit for In Vivo Control of GABA(A) Receptors and Synaptic Inhibition.
2015,
Pubmed
Lin,
Engineering a light-regulated GABAA receptor for optical control of neural inhibition.
2014,
Pubmed
,
Xenbase
Nourmahnad,
Tryptophan and Cysteine Mutations in M1 Helices of α1β3γ2L γ-Aminobutyric Acid Type A Receptors Indicate Distinct Intersubunit Sites for Four Intravenous Anesthetics and One Orphan Site.
2016,
Pubmed
,
Xenbase
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Pistis,
Complementary regulation of anaesthetic activation of human (alpha6beta3gamma2L) and Drosophila (RDL) GABA receptors by a single amino acid residue.
1999,
Pubmed
,
Xenbase
Ruesch,
An allosteric coagonist model for propofol effects on α1β2γ2L γ-aminobutyric acid type A receptors.
2012,
Pubmed
,
Xenbase
Sanna,
Actions of the general anesthetic propofol on recombinant human GABAA receptors: influence of receptor subunits.
1995,
Pubmed
,
Xenbase
Scott,
A structural perspective on GABAA receptor pharmacology.
2019,
Pubmed
Shin,
Propofol Is an Allosteric Agonist with Multiple Binding Sites on Concatemeric Ternary GABAA Receptors.
2018,
Pubmed
,
Xenbase
Siegwart,
Molecular determinants for the action of general anesthetics at recombinant alpha(2)beta(3)gamma(2)gamma-aminobutyric acid(A) receptors.
2002,
Pubmed
Stein,
Azo-propofols: photochromic potentiators of GABA(A) receptors.
2012,
Pubmed
Steinbach,
Modulation of GABA(A) receptor channel gating by pentobarbital.
2001,
Pubmed
Yip,
A propofol binding site on mammalian GABAA receptors identified by photolabeling.
2013,
Pubmed
Yue,
Robust photoregulation of GABA(A) receptors by allosteric modulation with a propofol analogue.
2012,
Pubmed
,
Xenbase
Ziemba,
Alphaxalone Binds in Inner Transmembrane β+-α- Interfaces of α1β3γ2 γ-Aminobutyric Acid Type A Receptors.
2018,
Pubmed
,
Xenbase
